TY  - GEN
AU  - Dienstag,Jules L
TI  - Benefits and risks of nucleoside analog therapy for hepatitis B
SN  - 1527-3350
PY  - 2009///0603
KW  - Administration, Oral
KW  - Antiviral Agents
KW  - administration & dosage
KW  - Hepatitis B virus
KW  - drug effects
KW  - Hepatitis B, Chronic
KW  - drug therapy
KW  - Humans
KW  - Nucleosides
KW  - Risk Factors
N1  - Publication Type: Consensus Development Conference, NIH; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/hep.22920
ER  -